Douglas C. Wallace, PhD, Director of the Center for Mitochondrial and Epigenomic Medicine at Children's Hospital of Philadelphia, was awarded the 2017 Dr. Paul Janssen Award for Biomedical Research on Sept. 13.
Sponsored by Johnson & Johnson, the Janssen Award annually recognizes outstanding scientific contributions from researchers of worldwide prominence, chosen by an independent selection committee that includes Nobel laureates and other distinguished scientists. The Award commemorates Dr. Paul Janssen, one of the most productive pharmaceutical researchers of the 20th century, who discovered and developed more than 80 medicines. During the Award ceremony, Dr. Wallace also was designated a Champion of Science, through the Dr. Paul Janssen Project, a new program that highlights the impact of science on humanity.
Dr. Wallace has achieved global prominence as the founder of mitochondrial genetics. Mitochondria are the tiny structures inside cells that produce 90 percent of our energy and play essential roles in health and disease.